XTANDI-Leuprolide boosts survival in non-metastatic hormone sensitive high risk Prostate cancer: Phase 3 EMBARK Trial Read more
Majority of Indian adults seek non-drug weight loss options amid safety concerns over GLP-1 medications Read more